[CYCC] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
10-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -11.39%
YoY- -2.19%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 373 0 0 0 0 0 0 -
PBT -6,034 -7,124 -9,000 -6,110 -5,559 -5,246 -6,491 -4.76%
Tax -586 -1,320 -1,581 -1,014 -984 -1,138 -1,197 -37.96%
NP -5,448 -5,804 -7,419 -5,096 -4,575 -4,108 -5,294 1.93%
Tax Rate - - - - - - - -
Total Cost 5,821 5,804 7,419 5,096 4,575 4,108 5,294 6.54%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -1,460.59 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -6.51 -6.94 -8.87 -0.41 -0.45 -0.41 -0.54 428.16%
EPS Diluted -6.51 -6.94 -8.87 -0.41 -0.45 -0.41 -0.54 428.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.